##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H119-301222-ROCHE_S67_R
1	103546235	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=5576;GeneNames=RNPC3;GeneIDs=55599;Aliases=CPHD7,IGHD5,RBM40,RNP,SNRNP65;Genes=1;TranscriptNameClinicallyRelevant=NM_017619.4;OverlappingExonsClinicallyRelevant=11-14;HGVSg=NC_000001.11:g.103546235_103551810dup;HGVScClinicallyRelevant=NM_017619.4:c.1208-13_1554dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=103551810	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:53.2771:2.04044:1.47805:0.000255317769942287:RNPC3::RNPC3:NM_017619.4:Benign:2L0ThiscnvpartiallyoverlapstheRNPC3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	149018542	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=9125;GeneNames=PDE4DIP;GeneIDs=9659;Aliases=CMYA2,MMGL;Genes=1;TranscriptNameClinicallyRelevant=NM_001395426.1;OverlappingExonsClinicallyRelevant=38-43;HGVSg=NC_000001.11:g.149018542_149027666dup;HGVScClinicallyRelevant=NM_001395426.1:c.5849_6867+39dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region2=1:149016307-149024139;Span3=7833;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=149027666	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:49.1573:2.26167:1.58476:4.93684342500774e-05:PDE4DIP::PDE4DIP:NM_001395426.1:Benign:2L0ThiscnvpartiallyoverlapsthePDE4DIPgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	46384718	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=836;GeneNames=EPAS1;GeneIDs=2034;Aliases=ECYT4,HIF2A,MOP2,PASD2,bHLHe73;Genes=1;TranscriptNameClinicallyRelevant=NM_001430.5;OverlappingExonsClinicallyRelevant=16;HGVSg=NC_000002.12:g.46384718_46385553dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(2)p21;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=46385553	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:124.932:2.75002:1.40632:1.90088975683335e-05:EPAS1::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
2	130576663	.	N	<DUP>	.	.	Type=Gain;Targets=13;Samples2=1;Span=78379;GeneNames=CFC1,POTEJ,PRSS40A;GeneIDs=150527,55997,653781;Aliases=TISP43;Genes=3;TranscriptNameClinicallyRelevant=NM_032545.4,NM_001277083.2,NR_027313.1;OverlappingExonsClinicallyRelevant=All,1-14,2-3;HGVSg=NC_000002.12:g.130576663_130655041dup;HGVScClinicallyRelevant=.,NM_001277083.2:c.1_1788dup,.;HGVSpClinicallyRelevant=.,NP_001264012.1:p.M1_E596dup,.;ISCNCytobandNotation=dup(2)q21.1;SequenceOntologyClinicallyRelevant=.,inframe_insertion,.;RegionClinicallyRelevant=.,exon,.;Region=2:130610736-130691652;Span2=80917;OverlapType=Partial Overlap;Name=gssvG21392;Frequency=1;Type2=Gain;END=130655041	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:69.6461:1.67335:1.56651:5.76869243015906e-08:CFC1,POTEJ,PRSS40A::POTEJ:NM_001277083.2:VUS:2L0ThiscnvpartiallyoverlapsthePOTEJgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	178530231	.	N	<DUP>	.	.	Type=Gain;Targets=51;Samples2=1;Span=84750;GeneNames=TTN,TTN-AS1;GeneIDs=100506866,7273;Genes=2;TranscriptNameClinicallyRelevant=NM_001267550.2,NR_038272.1;OverlappingExonsClinicallyRelevant=260-358,3-20;HGVSg=NC_000002.12:g.178530231_178614980dup;HGVScClinicallyRelevant=NM_001267550.2:c.48639-12_106374+10dup,.;HGVSpClinicallyRelevant=NP_001254479.2:p.A35459Nfs*7,.;ISCNCytobandNotation=dup(2)q31.2;SequenceOntologyClinicallyRelevant=frameshift_variant,.;RegionClinicallyRelevant=exon,.;END=178614980	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:161.072:2.64694:1.22593:4.21198462945881e-65:TTN,TTN-AS1:TTN:TTN:NM_001267550.2:VUS:2I0.45BothbreakpointsarewithintheTTNgeneandNMDisexpectedresultinginaFrameshiftVariantwithaPVS1Strongclassification,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	178657861	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=3;Span=1482;GeneNames=TTN;GeneIDs=7273;Aliases=CMD1G,CMH9,CMPD4,EOMFC,HMERF,LGMD2J,LGMDR10,MYLK5,SALMY,TMD;Genes=1;TranscriptNameClinicallyRelevant=NM_001267550.2;OverlappingExonsClinicallyRelevant=181-187;HGVSg=NC_000002.12:g.178657861_178659342dup;HGVScClinicallyRelevant=NM_001267550.2:c.37286-87_37873+20dup;HGVSpClinicallyRelevant=NP_001254479.2:p.A12432_E12627dup;ISCNCytobandNotation=dup(2)q31.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=178659342	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:70.5429:2.18487:2.16:2.02036156418287e-07:TTN:TTN:TTN:NM_001267550.2:Benign:2I0ThevarianthasanunknownimpactontheTTNgeneoritisnotpredictedtoundergoNMD.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	230310738	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=1958;GeneNames=SP140;GeneIDs=11262;Aliases=LYSP100,LYSP100-A,LYSP100-B;Genes=1;TranscriptNameClinicallyRelevant=NM_007237.5;OverlappingExonsClinicallyRelevant=24-27;HGVSg=NC_000002.12:g.230310738_230312695dup;HGVScClinicallyRelevant=NM_007237.5:c.2175-5_2604dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(2)q37.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=230312695	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:87.7729:2.05694:1.42737:0.000227033674010122:SP140::SP140:NM_007237.5:VUS:2L0ThiscnvpartiallyoverlapstheSP140genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	14142432	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=4963;GeneNames=TMEM43,XPC;GeneIDs=79188,7508;Aliases=ARVC5,ARVD5,AUNA3,EDMD7,EDMD7, AUNA2,LUMA;Genes=2;TranscriptNameClinicallyRelevant=NM_024334.3,NM_004628.5;OverlappingExonsClinicallyRelevant=12,15-16;HGVSg=NC_000003.12:g.14142432_14147394dup;HGVScClinicallyRelevant=.,NM_004628.5:c.2515-15_2823dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(3)p25.1;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=14147394	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:173.615:2.31162:1.29607:4.33638210161766e-10:TMEM43,XPC::XPC:NM_004628.5:VUS:2L0ThiscnvpartiallyoverlapstheXPCgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	48580549	.	N	<DUP>	.	.	Type=Gain;Targets=18;Samples2=1;Span=7014;GeneNames=COL7A1;GeneIDs=1294;Aliases=EBD1,EBDCT,EBR1,NDNC8;Genes=1;TranscriptNameClinicallyRelevant=NM_000094.4;OverlappingExonsClinicallyRelevant=23-55;HGVSg=NC_000003.12:g.48580549_48587562dup;HGVScClinicallyRelevant=NM_000094.4:c.2858-8_5052+32dup;HGVSpClinicallyRelevant=NP_000085.1:p.G1685Sfs*20;ISCNCytobandNotation=dup(3)p21.31;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=48587562	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:177.174:2.22057:1.22246:2.11922612074379e-17:COL7A1::COL7A1:NM_000094.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL7A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	124748035	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=454;GeneNames=UMPS;GeneIDs=7372;Aliases=OPRT;Genes=1;TranscriptNameClinicallyRelevant=NM_000373.4;OverlappingExonsClinicallyRelevant=6;HGVSg=NC_000003.12:g.124748035_124748488dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(3)q21.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=124748488	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:144.583:2.25333:1.4693:0.00047377922529509:UMPS::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
3	196806573	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=1;Span=7997;GeneNames=PAK2;GeneIDs=5062;Aliases=PAK65,PAKgamma;Genes=1;TranscriptNameClinicallyRelevant=NM_002577.4;OverlappingExonsClinicallyRelevant=6-11;HGVSg=NC_000003.12:g.196806573_196814569del;HGVScClinicallyRelevant=NM_002577.4:c.469-6_1053+1del;HGVSpClinicallyRelevant=NP_002568.2:p.L157_E351del;ISCNCytobandNotation=del(3)q29;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=196814569	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:76.1167:-2.60081:0.636022:9.86822386203042e-09:PAK2::PAK2:NM_002577.4:VUS:2B0WhiletheCNVoverlapsthePAK2geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37443inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
5	177724103	.	N	<DUP>	.	.	Type=Gain;Targets=13;Samples2=2;Span=24628;GeneNames=FAM153A;GeneIDs=285596;Aliases=NY-REN-7;Genes=1;TranscriptNameClinicallyRelevant=NM_001394339.1;OverlappingExonsClinicallyRelevant=3-21;HGVSg=NC_000005.10:g.177724103_177748730dup;HGVScClinicallyRelevant=NM_001394339.1:c.176-31_1164dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(5)q35.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=177748730	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:105.496:1.42388:1.53746:3.9968848796085e-06:FAM153A::FAM153A:NM_001394339.1:VUS:2L0ThiscnvpartiallyoverlapstheFAM153Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	31996519	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=32728;GeneNames=C4A,C4B,CYP21A1P,TNXA;GeneIDs=720,1590,7146,721;Aliases=C4,C4A2,C4A3,C4A4,C4A6,C4AD,C4S,CO4,CPAMD2,RG;Genes=4;TranscriptNameClinicallyRelevant=NM_007293.3,NM_001002029.4,NR_040090.1,NR_001284.2;OverlappingExonsClinicallyRelevant=28-41,1-28,All,All;HGVSg=NC_000006.12:g.31996519_32029246dup;HGVScClinicallyRelevant=NM_007293.3:c.3595_5235dup,NM_001002029.4:c.1_3584dup,.,.;HGVSpClinicallyRelevant=.,NP_001002029.3:p.T1196*,.,.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,frameshift_variant,.,.;RegionClinicallyRelevant=UTR3,exon,.,.;Region=6:31980357-32057861,6:31991099-32017745,6:32006063-32035417;Span2=77505,26647,29355;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvG32064,gssvG32065,gssvG32067;Frequency=0.2375,0.0071,0.1212;Type2=Gain,Gain,Gain;Region2=6:31991100-32017745,6:31991161-32017701;Span3=26646,26541;OverlapType2=Partial Overlap,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.92,0.175;DeletionFrequency=0,0;DuplicationFrequency=0.92,0.175;END=32029246	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:190.287:2.03898:2.08805:2.15854091369242e-07:C4A,C4B,CYP21A1P,TNXA::C4A:NM_007293.3:Benign:2L0ThiscnvpartiallyoverlapstheC4Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	50847058	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=560;GeneNames=TFAP2B;GeneIDs=7021;Aliases=AP-2B,AP-2beta,AP2-B,PDA2;Genes=1;TranscriptNameClinicallyRelevant=NM_003221.4;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000006.12:g.50847058_50847617dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(6)p12.3;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=50847617	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:111.572:2.43189:1.3731:0.000159238328762652:TFAP2B:TFAP2B:TFAP2B:NM_003221.4:VUS:2J0ThiscnvpartiallyoverlapstheTFAP2Bgene,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:3
6	116119340	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=2637;GeneNames=COL10A1,NT5DC1;GeneIDs=221294,1300;Aliases=C6orf200,LP2642,NT5C2L1;Genes=2;TranscriptNameClinicallyRelevant=NM_000493.4,NM_152729.3;OverlappingExonsClinicallyRelevant=3,.;HGVSg=NC_000006.12:g.116119340_116121976dup;HGVScClinicallyRelevant=NM_000493.4:c.155-15_2043dup,NM_152729.3:c.529+1394_529+1395ins(2637);HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(6)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation,intron_variant;RegionClinicallyRelevant=exon,intron;END=116121976	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:155.676:2.68018:1.33744:1.45542210138016e-06:COL10A1,NT5DC1::COL10A1:NM_000493.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL10A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	160613095	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=89295;GeneNames=LPA,PLG;GeneIDs=4018,5340;Aliases=AK38,APOA,LP;Genes=2;TranscriptNameClinicallyRelevant=NM_005577.4,NM_000301.5;OverlappingExonsClinicallyRelevant=1-15,1;HGVSg=NC_000006.12:g.160613095_160702389dup;HGVScClinicallyRelevant=NM_005577.4:c.1_2280dup,NM_000301.5:c.1_49+36dup;HGVSpClinicallyRelevant=NP_005568.2:p.M1_Y760dup,.;ISCNCytobandNotation=dup(6)q26;SequenceOntologyClinicallyRelevant=inframe_insertion,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region=6:160595829-160662125;Span2=66297;OverlapType=Partial Overlap;Name=gssvG33438;Frequency=0.0376;Type2=Gain;END=160702389	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:304.425:2.02093:1.95816:4.96163094211998e-08:LPA,PLG::LPA:NM_005577.4:VUS:2L0ThiscnvpartiallyoverlapstheLPAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
8	7450703	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=7;Span=35716;GeneNames=DEFB104B,DEFB106B,SPAG11B;GeneIDs=10407,503618,503841;Aliases=EDDM2B,EP2,EP2C,EP2D,HE2,HE2C,SPAG11;Genes=3;TranscriptNameClinicallyRelevant=NM_001040702.1,NM_001040704.2,NM_058201.4;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000008.11:g.7450703_7486418dup;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=8:7336299-7514711,8:7409831-7528213;Span2=178413,118383;OverlapType=Within Region,Within Region;Name=gssvG36586,gssvG36593;Frequency=0.0035,0.0016;Type2=Gain,Gain;Region2=8:7409844-7482669,8:7433398-7482669,8:7450654-7457984,8:7454115-7542809;Span3=72826,49272,7331,88695;OverlapType2=Partial Overlap,Partial Overlap,Partial Overlap,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.00371684,0.00152053,0.00118343,0.00202737;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.00371684,0.00152053,0.00118343,0.00202737;END=7486418	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:230.002:2.30153:1.83947:4.01787644328542e-07:DEFB104B,DEFB106B,SPAG11B::DEFB104B:NM_001040702.1:Benign:2D-1ThecnvissmallerthanthetriplobenignregionISCA-37472inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
8	7540930	.	N	<DUP>	.	.	Type=Gain;Targets=14;Samples2=2;Span=409827;GeneNames=DEFB4A,DEFB103A,DEFB104A,DEFB105A,DEFB106A,DEFB107A,FAM90A7,FAM90A8,FAM90A9,FAM90A10,FAM90A14,FAM90A16,FAM90A17,FAM90A18,FAM90A19,FAM90A22,FAM90A23,PRR23D1,PRR23D2,SPAG11A,ZNF705B;GeneIDs=100131608,441317,645558,645572,645651,441326,441323,441324,728746,728753,441327,441328,100133251,245910,245908,245909,140596,653423,414325,1673,100132396;Genes=21;TranscriptNameClinicallyRelevant=NM_004942.4,NM_001081551.4,NM_080389.3,NM_152250.3,NM_152251.4,NM_001037668.1,NM_001397387.1,NM_001164450.1,NM_001164448.1,NM_001164447.1,NM_001164452.1,NM_001397396.1,NM_001397391.1,NM_001164451.1,NM_001164449.1,NM_001397382.1,NM_001397380.1,NM_001282479.1,NM_001282478.1,NM_001395484.1,NM_001193630.1;OverlappingExonsClinicallyRelevant=All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,All,3-4,All,All,1-6;HGVSg=NC_000008.11:g.7540930_7950756dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,NM_001282479.1:c.140-22_840dup,.,.,NM_001193630.1:c.1_318+9dup;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,transcript_ablation,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,exon,.,.,exon;Region=8:6712833-8290078,8:7105219-7838739,8:7312955-8214781,8:7667128-7776100,8:7667461-8036387,8:7667461-8248986,8:7706040-7952372,8:7798647-7903250,8:7802093-7982308;Span2=1577246,733521,901827,108973,368927,581526,246333,104604,180216;OverlapType=Within Region,Partial Overlap,Within Region,Contains Region,Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG36566,gssvG36568,gssvG36567,gssvG36595,gssvG36574,gssvG36570,gssvG36582,gssvG36599,gssvG36587;Frequency=0.0071,0.0075,0.1192,0.2857,0.0019,0.0009,0.0034,0.002,0.0011;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=8:7777183-7972317;Span3=195135;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.0305795;DeletionFrequency=0;DuplicationFrequency=0.0305795;END=7950756	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:223.794:1.94795:1.85872:5.35113523416828e-11:DEFB4A,DEFB103A,DEFB104A,DEFB105A,DEFB106A,DEFB107A,FAM90A7,FAM90A8,FAM90A9,FAM90A10,FAM90A14,FAM90A16,FAM90A17,FAM90A18,FAM90A19,FAM90A22,FAM90A23,PRR23D1,PRR23D2,SPAG11A,ZNF705B::PRR23D1:NM_001282479.1:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-37472inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggenePRR23D1.,2L0ThiscnvpartiallyoverlapsthePRR23D1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps21proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
8	12112524	.	N	<DUP>	.	.	Type=Gain;Targets=14;Samples2=1;Span=81571;GeneNames=FAM66D,FAM85A,FAM86B1,FAM90A2P,LOC392196,USP17L2,USP17L7,ZNF705D;GeneIDs=728957,100132923,392196,392197,377630,729689,85002,619423;Aliases=ZNF705C;Genes=8;TranscriptNameClinicallyRelevant=NR_027425.1,NR_146925.1,NM_001083537.4,NR_046354.1,NR_003275.2,NM_201402.3,NM_001256869.2,NM_001039615.3;OverlappingExonsClinicallyRelevant=All,1,All,All,All,All,All,7;HGVSg=NC_000008.11:g.12112524_12194094dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.,NM_001039615.3:c.319-50_903dup;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(8)p23.1;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,.,.,.,.,exon;Region=8:12003313-12202446,8:12044191-12145208,8:12077151-12204348,8:12123435-12161515,8:12128021-12150032,8:12128105-12204348;Span2=199134,101018,127198,38081,22012,76244;OverlapType=Within Region,Partial Overlap,Within Region,Contains Region,Contains Region,Partial Overlap;Name=gssvG36755,gssvG36764,gssvG36761,gssvG36776,gssvG36784,gssvG36768;Frequency=0.0146,0.0017,0.0111,0.009,0.0388,0.0113;Type2=Gain,Gain,Gain,Gain,Gain,Gain;Region2=8:12128153-12150850;Span3=22698;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.425;DeletionFrequency=0;DuplicationFrequency=0.425;END=12194094	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:336.089:1.43546:1.53836:1.39118319475586e-06:FAM66D,FAM85A,FAM86B1,FAM90A2P,LOC392196,USP17L2,USP17L7,ZNF705D::ZNF705D:NM_001039615.3:Benign:2L0ThiscnvpartiallyoverlapstheZNF705Dgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
9	134842836	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=1974;GeneNames=COL5A1,LOC101448202;GeneIDs=1289,101448202;Aliases=EDSC,EDSCL1,FMDMF;Genes=2;TranscriptNameClinicallyRelevant=NM_000093.5,NR_103451.2;OverlappingExonsClinicallyRelevant=66,.;HGVSg=NC_000009.12:g.134842836_134844809dup;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(9)q34.3;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=134844809	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:171.517:2.13678:1.29632:2.56795734019151e-06:COL5A1,LOC101448202:COL5A1:COL5A1:NM_000093.5:VUS:2J0ThiscnvpartiallyoverlapstheCOL5A1gene,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:3
10	47491578	.	N	<DEL>	.	.	Type=Loss;Targets=8;Samples2=2;Span=31957;GeneNames=AGAP9,BMS1P2-AGAP9,FAM25G;GeneIDs=100133093,113939912,642517;Aliases=FAM25B,bA301J7.4;Genes=3;TranscriptNameClinicallyRelevant=NM_001190810.1,NR_160415.1,NM_001137549.2;OverlappingExonsClinicallyRelevant=All,9-16,1;HGVSg=NC_000010.11:g.47491578_47523534del;HGVScClinicallyRelevant=.,.,NM_001137549.2:c.1_73+24del;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=del(10)q11.22;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation;RegionClinicallyRelevant=.,.,exon;Region=10:47490407-47526257;Span2=35851;OverlapType=Within Region;Name=gssvL12174;Frequency=0.403;Type2=Loss;END=47523534	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:32.6067:-2.32689:0.206564:3.14696658350412e-09:AGAP9,BMS1P2-AGAP9,FAM25G::AGAP9:NM_001190810.1:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46443inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
10	48178040	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=9263;GeneNames=FRMPD2;GeneIDs=143162;Aliases=PDZD5C,PDZK4,PDZK5C;Genes=1;TranscriptNameClinicallyRelevant=NM_001018071.4;OverlappingExonsClinicallyRelevant=17-22;HGVSg=NC_000010.11:g.48178040_48187302dup;HGVScClinicallyRelevant=NM_001018071.4:c.2166-10_2895+7dup;HGVSpClinicallyRelevant=NP_001018081.4:p.G966Pfs*38;ISCNCytobandNotation=dup(10)q11.22;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=48187302	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:113.107:2.04108:1.3444:4.21441164323191e-05:FRMPD2::FRMPD2:NM_001018071.4:Benign:2L0ThiscnvpartiallyoverlapstheFRMPD2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
11	65616814	.	N	<DUP>	.	.	Type=Gain;Targets=17;Samples2=1;Span=8945;GeneNames=PCNX3;GeneIDs=399909;Aliases=PCNXL3;Genes=1;TranscriptNameClinicallyRelevant=NM_032223.4;OverlappingExonsClinicallyRelevant=2-19;HGVSg=NC_000011.10:g.65616814_65625758dup;HGVScClinicallyRelevant=NM_032223.4:c.154-10_3228+14dup;HGVSpClinicallyRelevant=NP_115599.2:p.V52_K1076dup;ISCNCytobandNotation=dup(11)q13.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=65625758	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:174.04:2.25664:1.22149:5.21993240641545e-17:PCNX3::PCNX3:NM_032223.4:VUS:2L0ThiscnvpartiallyoverlapsthePCNX3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	89800870	.	N	<DUP>	.	.	Type=Gain;Targets=11;Samples2=1;Span=111232;GeneNames=LOC642414,TRIM49,TRIM49D1,TRIM64B;GeneIDs=57093,642414,642446,399939;Aliases=RNF18,TRIM49A,TRIM49L2;Genes=4;TranscriptNameClinicallyRelevant=NR_169306.1,NM_020358.2,NM_001384911.1,NM_001164397.3;OverlappingExonsClinicallyRelevant=All,1-6,8,All;HGVSg=NC_000011.10:g.89800870_89912101dup;HGVScClinicallyRelevant=.,NM_020358.2:c.1_761+96dup,NM_001384911.1:c.860-15_1359dup,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(11)q14.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=.,exon,exon,.;END=89912101	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:175.717:1.35521:1.39544:5.52597928055877e-05:LOC642414,TRIM49,TRIM49D1,TRIM64B::TRIM49:NM_020358.2:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46459inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneTRIM49.,2L0ThiscnvpartiallyoverlapstheTRIM49genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
11	119305536	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=832;GeneNames=CBL;GeneIDs=867;Aliases=C-CBL,CBL2,FRA11B,NSLL,RNF55;Genes=1;TranscriptNameClinicallyRelevant=NM_005188.4;OverlappingExonsClinicallyRelevant=16;HGVSg=NC_000011.10:g.119305536_119306367dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(11)q23.3;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=119306367	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:152.012:2.80111:1.39334:1.32188854437968e-05:CBL::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
12	31087900	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=1;Span=8521;GeneNames=DDX11;GeneIDs=1663;Aliases=CHLR1,KRG2,WABS;Genes=1;TranscriptNameClinicallyRelevant=NM_030653.4;OverlappingExonsClinicallyRelevant=6-15;HGVSg=NC_000012.12:g.31087900_31096420dup;HGVScClinicallyRelevant=NM_030653.4:c.639-38_1521+41dup;HGVSpClinicallyRelevant=NP_085911.2:p.L508Sfs*3;ISCNCytobandNotation=dup(12)p11.21;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region2=12:31073883-31101139;Span3=27257;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=31096420	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:128.111:1.86425:1.31649:1.15109614642947e-07:DDX11::DDX11:NM_030653.4:VUS:2L0ThiscnvpartiallyoverlapstheDDX11genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	40478954	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=6862;GeneNames=MUC19;GeneIDs=283463;Aliases=MUC-19;Genes=1;TranscriptNameClinicallyRelevant=NM_173600.2;OverlappingExonsClinicallyRelevant=56-57;HGVSg=NC_000012.12:g.40478954_40485815dup;HGVScClinicallyRelevant=NM_173600.2:c.6101-99_12862dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q12;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=12:40474072-40491330,12:40480537-40486052,12:40481450-40490785;Span2=17259,5516,9336;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvG8621,gssvG8837,gssvG8725;Frequency=0.0084,0.002,0.0128;Type2=Gain,Gain,Gain;Region2=12:40482234-40483958;Span3=1725;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.0236686;DeletionFrequency=0;DuplicationFrequency=0.0236686;END=40485815	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:706.423:2.68394:1.30757:1.40664748921192e-06:MUC19::MUC19:NM_173600.2:VUS:2L0ThiscnvpartiallyoverlapstheMUC19genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	51808687	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=1464;GeneNames=SCN8A;GeneIDs=6334;Aliases=BFIS5,CERIII,CIAT,DEE13,EIEE13,MED,MYOCL2,NaCh6,Nav1.6,PN4;Genes=1;TranscriptNameClinicallyRelevant=NM_014191.4;OverlappingExonsClinicallyRelevant=27;HGVSg=NC_000012.12:g.51808687_51810150dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q13.13;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=51810150	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:112.52:2.33924:1.41558:2.60504970800058e-06:SCN8A::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
12	56933952	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=70974;GeneNames=GPR182,RDH16,SDR9C7,ZBTB39;GeneIDs=121214,8608,11318,9880;Aliases=ARCI13,RDHS,SDR-O,SDRO;Genes=4;TranscriptNameClinicallyRelevant=NM_007264.4,NM_003708.5,NM_148897.3,NM_014830.3;OverlappingExonsClinicallyRelevant=All,All,1,2;HGVSg=NC_000012.12:g.56933952_57004925dup;HGVScClinicallyRelevant=.,.,NM_148897.3:c.1_301+9dup,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(12)q13.3;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation,.;RegionClinicallyRelevant=.,.,exon,.;Region=12:56929925-56988848;Span2=58924;OverlapType=Partial Overlap;Name=gssvG8487;Frequency=0.0015;Type2=Gain;Region2=12:56937399-56985796;Span3=48398;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.025;DeletionFrequency=0;DuplicationFrequency=0.025;END=57004925	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:184.127:2.37253:1.24879:1.48815267633344e-10:GPR182,RDH16,SDR9C7,ZBTB39::SDR9C7:NM_148897.3:VUS:2L0ThiscnvpartiallyoverlapstheSDR9C7genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	57746156	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=2169;GeneNames=CDK4,TSPAN31;GeneIDs=6302,1019;Aliases=SAS;Genes=2;TranscriptNameClinicallyRelevant=NM_000075.4,NM_005981.5;OverlappingExonsClinicallyRelevant=8,3-6;HGVSg=NC_000012.12:g.57746156_57748324dup;HGVScClinicallyRelevant=.,NM_005981.5:c.232-20_633dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(12)q14.1;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=57748324	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.248:2.17886:1.32307:1.61839522738578e-06:CDK4,TSPAN31::TSPAN31:NM_005981.5:VUS:2L0ThiscnvpartiallyoverlapstheTSPAN31genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
13	83878045	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=540;GeneNames=SLITRK1;GeneIDs=114798;Aliases=LRRC12,TTM;Genes=1;TranscriptNameClinicallyRelevant=NM_052910.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000013.11:g.83878045_83878584dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(13)q31.1;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=83878584	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:144.748:2.38992:1.39715:1.77674128942824e-05:SLITRK1::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
16	2503293	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=1847;GeneNames=TBC1D24;GeneIDs=57465;Aliases=DEE16,DFNA65,DFNB86,DOORS,EIEE16,EPRPDC,FIME,TLDC6;Genes=1;TranscriptNameClinicallyRelevant=NM_001199107.2;OverlappingExonsClinicallyRelevant=8;HGVSg=NC_000016.10:g.2503293_2505139dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p13.3;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=2505139	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:158.401:2.31698:1.34235:3.24563570340697e-06:TBC1D24::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
16	72059096	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=16147;GeneNames=HP,HPR;GeneIDs=3240,3250;Aliases=BP,HP2ALPHA2,HPA1S;Genes=2;TranscriptNameClinicallyRelevant=NM_005143.5,NM_020995.4;OverlappingExonsClinicallyRelevant=6-7,1-4;HGVSg=NC_000016.10:g.72059096_72075242dup;HGVScClinicallyRelevant=NM_005143.5:c.368-18_1221dup,NM_020995.4:c.1_268+23dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(16)q22.2;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region=16:72053111-72084772;Span2=31662;OverlapType=Within Region;Name=gssvG15245;Frequency=0.0546;Type2=Gain;Region2=16:72054602-72078328,16:72054602-72078398,16:72056626-72077707;Span3=23727,23797,21082;OverlapType2=Within Region,Within Region,Within Region;Type3=Duplication,Duplication,Duplication;Frequency2=0.125,0.98,0.025;DeletionFrequency=0,0,0;DuplicationFrequency=0.125,0.98,0.025;END=72075242	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:126.764:1.6683:1.32958:0.000250440453401932:HP,HPR::HP:NM_005143.5:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46692inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneHP.,2L0ThiscnvpartiallyoverlapstheHPgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	84009770	.	N	<DUP>	.	.	Type=Gain;Targets=28;Samples2=1;Span=83533;GeneNames=MBTPS1,SLC38A8;GeneIDs=146167,8720;Aliases=FVH2;Genes=2;TranscriptNameClinicallyRelevant=NM_003791.4,NM_001080442.3;OverlappingExonsClinicallyRelevant=6-23,All;HGVSg=NC_000016.10:g.84009770_84093302dup;HGVScClinicallyRelevant=NM_003791.4:c.737-5_3159dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(16)q23.3;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;END=84093302	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:221.691:2.98523:1.40512:5.2367783142749e-46:MBTPS1,SLC38A8::MBTPS1:NM_003791.4:VUS:2L0ThiscnvpartiallyoverlapstheMBTPS1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	86513934	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=27322;GeneNames=FOXF1,MTHFSD;GeneIDs=2294,64779;Aliases=ACDMPV,FKHL5,FREAC1;Genes=2;TranscriptNameClinicallyRelevant=NM_001451.3,NM_001159377.2;OverlappingExonsClinicallyRelevant=2,8;HGVSg=NC_000016.10:g.86513934_86541255dup;HGVScClinicallyRelevant=.,NM_001159377.2:c.681+442_1152dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(16)q24.1;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=86541255	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:170.022:2.58711:1.41077:1.9762595778732e-07:FOXF1,MTHFSD:FOXF1:FOXF1:NM_001451.3:VUS:2J0ThiscnvpartiallyoverlapstheFOXF1gene,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	20449963	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=3;Span=3140;GeneNames=LGALS9B;GeneIDs=284194;Genes=1;TranscriptNameClinicallyRelevant=NM_001367292.2;OverlappingExonsClinicallyRelevant=7-11;HGVSg=NC_000017.11:g.20449963_20453102dup;HGVScClinicallyRelevant=NM_001367292.2:c.577-35_1071dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=20453102	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:235.329:2.60025:1.66749:2.97632475615039e-06:LGALS9B::LGALS9B:NM_001367292.2:Benign:2L0ThiscnvpartiallyoverlapstheLGALS9Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	81902268	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=1;Span=5368;GeneNames=NPB,PCYT2;GeneIDs=5833,256933;Aliases=ET,SPG82;Genes=2;TranscriptNameClinicallyRelevant=NM_148896.5,NM_002861.5;OverlappingExonsClinicallyRelevant=All,6-13;HGVSg=NC_000017.11:g.81902268_81907635dup;HGVScClinicallyRelevant=.,NM_002861.5:c.493-37_1170dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(17)q25.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=81907635	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:169.286:2.25531:1.25758:1.36724067892125e-10:NPB,PCYT2::PCYT2:NM_002861.5:VUS:2L0ThiscnvpartiallyoverlapsthePCYT2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
20	1915066	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=7589;GeneNames=SIRPA;GeneIDs=140885;Aliases=BIT,CD172A,MFR,MYD-1,P84,PTPNS1,SHPS1,SIRP;Genes=1;TranscriptNameClinicallyRelevant=NM_001040023.2;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000020.11:g.1915066_1922654dup;HGVScClinicallyRelevant=NM_001040023.2:c.80-33_1087+9dup;HGVSpClinicallyRelevant=NP_001035112.1:p.G27_A362dup;ISCNCytobandNotation=dup(20)p13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=1922654	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:334.192:2.90115:1.3497:1.8150274608782e-07:SIRPA::SIRPA:NM_001040023.2:VUS:2L0ThiscnvpartiallyoverlapstheSIRPAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
20	58676452	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=1278;GeneNames=STX16,STX16-NPEPL1;GeneIDs=100534593,8675;Genes=2;TranscriptNameClinicallyRelevant=NM_001001433.3,NR_037945.1;OverlappingExonsClinicallyRelevant=9,.;HGVSg=NC_000020.11:g.58676452_58677729dup;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(20)q13.32;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=58677729	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:164.357:2.43852:1.32368:9.54631256992555e-07:STX16,STX16-NPEPL1::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
21	44108980	.	N	<DEL>	.	.	Type=Loss;Targets=12;Samples2=38;Span=36676;GeneNames=GATD3,PWP2;GeneIDs=5822,8209;Aliases=EHOC-17,PWP2H,UTP1;Genes=2;TranscriptNameClinicallyRelevant=NM_004649.8,NM_005049.3;OverlappingExonsClinicallyRelevant=All,2-21;HGVSg=NC_000021.9:g.44108980_44145655del;HGVScClinicallyRelevant=.,NM_005049.3:c.19-4_2760del;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(21)q22.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=44145655	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-1.46717:0:4.94164672581577e-06:GATD3,PWP2::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:0
22	23957713	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=3;Span=19231;GeneNames=DDT,DDTL,GSTT2B;GeneIDs=653689,100037417,1652;Aliases=GSTT2P;Genes=3;TranscriptNameClinicallyRelevant=NM_001084392.3,NM_001084393.2,NM_001080843.4;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000022.11:g.23957713_23976943dup;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(22)q11.23;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=22:23925904-24002223,22:23927243-23971405,22:23971365-23979830;Span2=76320,44163,8466;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvG24259,gssvG24274,gssvG24325;Frequency=0.0209,0.001,0.75;Type2=Gain,Gain,Gain;END=23976943	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:247.087:2.71052:1.93166:1.08074363541364e-10:DDT,DDTL,GSTT2B::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps3proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
22	32860904	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=1;Span=4116;GeneNames=SYN3,TIMP3;GeneIDs=8224,7078;Genes=2;TranscriptNameClinicallyRelevant=NM_003490.4,NM_000362.5;OverlappingExonsClinicallyRelevant=6,5;HGVSg=NC_000022.11:g.32860904_32865019dup;HGVScClinicallyRelevant=NM_003490.4:c.622-15_711+4011dup,.;HGVSpClinicallyRelevant=NP_003481.3:p.F208_M237dup,.;ISCNCytobandNotation=dup(22)q12.3;SequenceOntologyClinicallyRelevant=inframe_insertion,.;RegionClinicallyRelevant=exon,.;END=32865019	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:162.236:2.46427:1.35811:2.27293326748638e-12:SYN3,TIMP3::SYN3:NM_003490.4:VUS:2L0ThiscnvpartiallyoverlapstheSYN3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
X	149545622	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=52642;GeneNames=EOLA1,HSFX2,HSFX3,MAGEA9B,TMEM185A;GeneIDs=91966,101928917,728269,100130086,84548;Aliases=CXorf40,CXorf40A;Genes=5;TranscriptNameClinicallyRelevant=NM_001171907.3,NM_001164415.3,NM_001323079.3,NM_001080790.1,NM_032508.4;OverlappingExonsClinicallyRelevant=4-5,All,All,All,7;HGVSg=NC_000023.11:g.149545622_149598263dup;HGVScClinicallyRelevant=.,.,.,.,NM_032508.4:c.809-8_1053dup;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(X)q28;SequenceOntologyClinicallyRelevant=.,.,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,.,exon;Region2=X:149562351-149573041;Span3=10691;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.075;DeletionFrequency=0;DuplicationFrequency=0.075;END=149598263	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:152.909:3.30882:1.62296:3.42439610054556e-17:EOLA1,HSFX2,HSFX3,MAGEA9B,TMEM185A::TMEM185A:NM_032508.4:VUS:2L0ThiscnvpartiallyoverlapstheTMEM185Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps5proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
X	149929635	.	N	<DEL>	.	.	Type=Loss;Targets=5;Samples2=1;Span=4248;GeneNames=EOLA2,HSFX4;GeneIDs=101927685,541578;Genes=2;TranscriptNameClinicallyRelevant=NM_001013845.2,NM_001351114.2;OverlappingExonsClinicallyRelevant=4-5,All;HGVSg=NC_000023.11:g.149929635_149933882del;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(X)q28;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=149933882	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0.45259:-5.66925:0.0138729:3.0345887084661e-30:EOLA2,HSFX4::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:0
